These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7308260)

  • 1. Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against transplantable leukemias.
    Santelli G; Valeriote F; Vietti T; Coulter D
    Eur J Cancer (1965); 1981 Jun; 17(6):629-34. PubMed ID: 7308260
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM; Gale GR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL; Carter WH; Campbell ED
    Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
    Gale GR; Walker EM; Atkins LM; Smith AB; Meischen SJ
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):529-38. PubMed ID: 4824827
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia.
    Gale GR; Atkins LM; Schwartz P; Meischen SJ
    Bioinorg Chem; 1978; 8(5):445-51. PubMed ID: 687671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G; Valeriote F
    Cancer Chemother Pharmacol; 1986; 18(2):101-4. PubMed ID: 3791555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Fernandes DJ; Klubes P
    Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent cytotoxicity of 5-fluorouracil in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1986 Jan; 76(1):159-64. PubMed ID: 3455738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.
    Sava G; Giraldi T; Perissin L; Zorzet S; Decorti G
    Clin Exp Metastasis; 1987; 5(1):27-34. PubMed ID: 2951046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor activity of cyclocytidine in a variety of tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
    Stoichkov I; Milushev A; Todorov D
    Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.